Rivaara Labs

Home
India
Mumbai
Rivaara Labs

Rivaara Labs is an exclusive lab chain for molecular diagnostics in India.

25/01/2026

This Republic Day, we celebrate the spirit of India and our shared responsibility to build a healthier nation.

At Rivaara Labs, we remain committed to advancing molecular diagnostics that support timely, precise, and responsible clinical care.

🇮🇳 Happy Republic Day!

13/01/2026

AMR: From National Concern to Clinical Action

In a recent Mann Ki Baat, Hon’ble Prime Minister Shri Narendra Modi highlighted a growing threat to public health — common infections are becoming harder to treat as antibiotics lose effectiveness, citing data generated by ICMR’s national AMR surveillance.

This is a crucial reminder that AMR is not a future risk — it is a present clinical reality, especially in infections such as pneumonia, UTIs, sepsis, and ICU-associated infections.

At RIVAARA, we believe antimicrobial stewardship begins with the laboratory.

Timely, accurate diagnostic insights can help:
Identify the true causative pathogen
Detect key resistance mechanisms early
Reduce unnecessary empirical antibiotic escalation
Support evidence-based, targeted therapy.

Our diagnostic panels are designed to support clinicians in making faster, informed treatment decisions, aligning with national AMR containment goals outlined by ICMR.

🔬 Right diagnosis → Right antibiotic → Right time

This is how laboratories and clinicians can work together to preserve the effectiveness of antibiotics for future generations.

11/01/2026

SPOT SEPSIS. STOP SEPSIS.

Post-transplant sepsis remains one of the most critical challenges in clinical care—made even more complex by India’s high burden of antimicrobial resistance (AMR).

Over 30% of sepsis-related deaths in India are linked to antibiotic resistance, posing a serious risk in post-transplant patients, where timely and precise decisions are crucial.

In this testimonial, Dr. Rahul Kendre (Transplant Physician, Dr. D. Y. Patil Hospital, Pune) shares key learnings from a real-world post-transplant sepsis case, highlighting how early and accurate pathogen & resistance detection can help reduce unnecessary broad-spectrum antibiotic use and support better outcomes.

At Rivaara Labs, we are committed to supporting clinicians with rapid molecular diagnostics that enable timely, targeted therapy and stronger antimicrobial stewardship—when every hour matters.

04/01/2026

Cervical cancer is preventable—if detected early
So,Screen Early, Screen Right.

As global awareness efforts kick off (Jan 1–7, 2026), this testimonial from Dr. Priti Vyas reinforces why HPV + LBC co-testing is critical for effective cervical cancer screening.

Rivaaras HPV & LBC testing services are helping clinicians make screening more impactful during this global awareness drive.

HPV + LBC co-testing enables earlier detection, better clinical decisions, and better outcomes for women.

Rivaaras is proud to support this mission.

29/12/2025

SPOT SEPSIS STOP SEPSIS

Sepsis care is evolving. So should our diagnostics.

In this short testimonial, Dr. Dinesh Wagh (Nashik) shares a real sepsis case, underscoring how early, precise molecular diagnosis can guide timely and targeted therapy.
In the era of rising AMR, sepsis management isn’t just about starting antibiotics early—
it’s about choosing the right antibiotic, at the right time, for the right patient.
Rapid pathogen and resistance detection enables de-escalation, reduces empirical overuse, and strengthens antimicrobial stewardship—leading to better outcomes when every hour counts.

SPOT SEPSIS STOP SEPSIS.

01/12/2025

🌍 On World AIDS Day let’s close the gap between infection and diagnosis.
With 39.9 million people living with HIV — and 1 in 5 unaware of their status — timely testing is crucial. This reminds us that awareness and early diagnosis save lives.
Accurate molecular diagnostics remain a key pillar in identifying infections sooner and improving patient outcomes.
At RIVAARA Labs, we stand with clinicians, caregivers, and communities working to end the stigma and strengthen early detection.
Act today. Test early. Stay informed.

24/11/2025

World AMR Week highlights one undeniable truth - diagnostics are the first step in defeating AMR.

Our AMR Panels enable early detection, targeted therapy, improved stewardship, and ultimately, better outcomes.

At Rivaara Labs, we continue our commitment to rapid, precise, and reliable AMR testing.

Act Now, Protect Our Present, Secure Our Future.

22/11/2025

AMR is one of India’s fastest-growing healthcare threats. Its burden is rising, and so is the urgency to act.

In this video, Dr.Girish Gaur (Chief Operating Officer) Rivaara Labs Pvt Ltd., talks about the growing challenges in antimicrobial resistance and the role of molecular diagnostics in detecting resistance early, which is guiding therapy, improving patient outcomes. and targeted decision-making.

At Rivaara Labs, we’re committed to empowering clinicians with better diagnostics for better decisions
Better diagnostics today means stronger patient outcomes tomorrow.
Act Now, Protect Our Present, Secure Our Future.

20/11/2025

Carbapenems are failing. Cephalosporins are failing. Even colistin is showing cracks.
AMR in India is escalating - and so must our response.
Act Now, Protect Our Present, Secure Our Future.
Better diagnostics. Better decisions. Better outcomes.

18/11/2025

Antimicrobial Resistance (AMR) is no longer a distant threat - it's a present and accelerating crisis.

From rising superbugs to delayed diagnostics and limited treatment options, clinicians face unprecedented challenges in delivering effective care.

Here is some information of global and Indian AMR landscape, the clinical impact, and what we must do now to protect the future of medicine.

Stronger diagnostics, stewardship, and One Health action are essential. Let's raise awareness. Let's act with purpose.

17/11/2025

Antimicrobial Resistance (AMR) is an invisible threat that cannot be seen but is continuously growing
It’s reshaping how we diagnose, treat, and manage infections.
AMR is rising quietly, turning routine infections into life-threatening challenges.
It is silently advancing—impacting outcomes, increasing complexity, and challenging the treatment.
The silent threat demands urgent attention.

Are we ready to act on it?
This World AMR Awareness Week,
Stay tuned with us as we are with you to fight with this silent storm.
Let’s break the silence together

11/10/2025

See beyond traditional culture.
Some pathogens won’t grow. Others take days.
SeptiQuik™ DR detects AMR genes (NDM, OXA, KPC, VIM, mecA & more) directly from blood or body fluids - helping your team act faster and smarter.

Learn More: https://rivaaralabs.com/septiquik-panels/

Address

17th Floor, Hoechst House, Nariman Point
Mumbai
400021

Telephone

+919301000083

Website

https://rivaaralabs.com/

Alerts

Be the first to know and let us send you an email when Rivaara Labs posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Rivaara Labs:

Shortcuts

Want your practice to be the top-listed Clinic in Mumbai?